TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Moderna Inc (MRNA)

Healthcare Biotechnology
55.10 $
+0.6% vs. previous close
Closing price · As of: 3. Aug 2026

Moderna Inc (MRNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,944 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement MRNA
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.5 0.0 108 206 123 48 274 17,736 18,875 6,848 3,199 1,944
0.0 0.0 15 21 454 496 7.9 2,617 5,416 4,693 1,464 868
0.5 0.0 93 185 -332 48 267 15,119 13,459 2,155 1,735 1,076
0.7 0.3 275 410 454 496 1,370 1,991 3,295 4,845 4,543 3,132
3.3 0.8 57 65 94 110 188 567 1,011 1,345 1,028 1,018
0.0 1.1 317 455 536 594 1,030 1,823 4,039 6,394 5,680 4,150
-3.5 -1.1 -224 -269 -413 -546 -763 13,296 9,420 -4,239 -3,945 -3,074
0.0 0.0 0.0 0.1 3.1 6.6 9.9 18 29 38 24 10
-6.5 -1.1 -215 -256 -384 -515 -745 13,285 9,575 -3,942 -3,607 -2,768
0.0 0.0 1.0 -0.1 0.3 -0.7 2.6 1,083 1,213 772 -46 54
-6.5 -1.1 -216 -256 -385 -514 -747 12,202 8,362 -4,714 -3,561 -2,822
-209 -235 -388 -515 -732 13,528 9,952 -3,283 -3,394 -2,553

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?